We found that bafilomycin A1-treated AAAs reduced contractile protein expression in VSMCs and increased expression of the synthetic phenotype marker OPN, indicating that bafilomycin A1 promotes VSMC phenotypic switching and vascular injury (Figures 9B,C). This evidence concerns the gene SPP1 and achalasia-alacrima syndrome.